Switzerland· 59035001
Mydriasert, insert ophtalmique
A tropicamid, kombinationen product containing phenylephrini hydrochloridum, tropicamidum, registered in Switzerland by THEA Pharma S.A. and dispensed under Swissmedic category B. The same ATC class is registered in 10 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tropicamid, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC S01FA56 (tropicamid, kombinationen), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Tropicamid, kombinationen · ATC S01FA56
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- phenylephrini hydrochloridum, tropicamidum
- Manufacturer
- THEA Pharma S.A.
- Country
- Switzerland (CH)
- ATC code
- S01FA56
- ATC class
- Tropicamid, Kombinationen
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tropicamid, kombinationen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMydriasert, ooginsert 0,28 mg en 5,4 mgEuro Registratie Collectief B.V.
- GermanyMydriasertLaboratoires Thea
- SpainMYDRIASERT 0,28 mg/5,4 mg INSERTO OFTALMICOLaboratoires Thea
- FinlandMydriasertLaboratoires Thea
- FranceMYDRIASERT, insert ophtalmiqueTHEA
- United KingdomMydriasert 5.4mg/0.28mg ophthalmic insertsThea Pharmaceuticals Ltd
- NorwayMydriasertLaboratoires Théa
- SwedenMydriasert 0,28 mg/5,4 mg ÖgonlamellLaboratoires THEA
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Mydriasert
- Belgium · Mydriasert
- Germany · Mydriasert
- Denmark · Mydriasert
- Spain · Mydriasert
- Finland · Mydriasert
- France · Mydriasert
- United Kingdom (Northern Ireland) · Mydriasert
- Italy · Mydriasert, Visumidriatic Fenilefrina
- Luxembourg · Mydriasert
- Netherlands · Mydriasert
- Portugal · Mydriasert
- Sweden · Mydriasert
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24b60c73-527f-4c8e-adc9-70ec740af79e GET /v1/drugs/24b60c73-527f-4c8e-adc9-70ec740af79e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about tropicamid, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.